News

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.
In a video shared to TikTok via her page, @lucy52915, which has racked up more than 750,000 views, she revealed pictures of ...
NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer Former Amgen, Novo Nordisk and Boehringer Ingelheim senior leader joins NodThera Leadership TeamWill spearhead clinical ...
The joint effort will focus on providing patients with medication guidance, reminders, tracking of efficacy and health education.
You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...
The stock needs a compound annual growth rate of 12.2% to double in the next six years. Novo Nordisk can pull it off, ...
A study reveals potentially fatal side effects of GLP-1 drugs, that people are using to lose weight. It’s well known that ...
Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...
With their lengthening laundry list of health benefits, drugs like Ozempic are showing promise for people who struggle with addiction.
Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...